is an herb that is increasingly used in oncology research and treatment settings. Historically, it has been used to treat liver and biliary disorders and has been used in detoxification and cleansing protocols. However, milk thistle is increasingly being investigated for its use in adult and pediatric populations for oncology indications. Possible indications during cancer treatment include cleansing and detoxification after chemotherapy, preventing hepatotoxicity during chemotherapy, treating hepatotoxicity after chemotherapy, and potentiating chemotherapy and radiation therapy as an adjunctive treatment. Milk thistle may also have applications in ameliorating longterm hepatic and cardiovascular effects of cancer treatment. Preliminary studies are investigating its use as a chemopreventive agent and possibly to treat cancer directly. Much of milk thistle's current clinical use grows out of historical uses but is informed by an increasing number of clinical trials and animal studies. This article provides an overview of the current clinical applications of milk thistle in the oncology setting, including guidelines on commonly used forms and doses.
Milk thistle (Silybum marianum [L.] Gaertn., plant family Asteraceae) seed is an herb commonly used by Western herbalists and naturopathic physicians to treat liver disorders in adults. The German Commission E currently recommends its use for dyspeptic complaints, toxin-induced liver damage, and hepatic cirrhosis and as a supportive therapy for chronic inflammatory liver conditions. 1 However, milk thistle is increasingly used in research and clinical practice in adult and pediatric populations in the oncology setting. It is being used for detoxification after chemotherapy, as a hepatoprotectant during chemotherapy, as an adjunct to cancer treatment, and to ameliorate long-term effects of cancer treatment. Researchers are actively investigating its role as a chemopreventive agent and possible treatment of cancer.
Much of milk thistle's current clinical use is based on recent research on the actions of silymarin, milk thistle's flavonoid complex. The plant in its whole form, however, has a long history of use that has not been fully explored. In its native Mediterranean region, it has been used for liver ailments since the Greco-Roman era, and today it remains in folk use as a digestive aid, aperient, anti-inflammatory, antineoplastic, hypotensive, styptic, diuretic, and general tonifier. 2 Other confirmed folk applications include its use for pruritus, hemorrhoids, colic, malaria, and psoriasis, and as a galactagogue. 3 Milk thistle traveled to North America with the Europeans and was used by North American physicians to treat gallstones, vomiting in pregnancy, amenorrhea, uterine hemorrhage, hematuria, painful dysuria, and congestion of the liver, spleen, or kidneys. 2 One of the more recent directions of milk thistle research is its use in oncology. Silymarin and silibinin (1 of the components of silymarin, also called silibin or silybin) have been evaluated for their ability to exert direct cytotoxic effects, mitigate toxicity of certain anticancer agents, and enhance the efficacy of chemotherapeutic agents. Milk thistle is increasingly used as an adjunct treatment for many types of cancer, with recent research also suggesting cancer prevention applications.
In this article we describe current and potential clinical applications of milk thistle in the oncology setting. Milk thistle use is usually based on historical indications. Very little clinical research has been conducted in this area, but when possible, research will be presented as supporting evidence.
Cleansing and Detoxification
The concepts of cleansing and detoxification are shared by many forms of herbalism and nonallopathic systems of medicine, such as naturopathy, traditional Chinese medicine, and Ayurvedic medicine. These processes are intended to balance and tonify the body. The goal is to reestablish full health and vitality after or during an illness, to prevent illness, or to increase a sense of wellness. Cleansing and detoxification are primarily used to set the stage for a patient's change to a more healthful lifestyle or as a periodic, often seasonal, adherence to a simple regimen to compensate for lapses in diet, exercise, and other habits. However, detoxification is also used to detoxify or reduce the negative effects of excess weight, a history of heavy alcohol use, exposure to steroids, exogenous hormones, chemicals, heavy metals, and drugs, including chemotherapy. 4 Adult and pediatric oncology patients frequently request information on botanicals (herbs) they can use to cleanse and detoxify between chemotherapy cycles or after treatment. 5, 6 In the oncology setting, cleansing and detoxifying are often perceived to be beneficial because this process is thought to rid the body of residual toxic chemotherapy drugs and improve the body's ability to metabolize the drugs. Milk thistle is 1 of the botanicals commonly used for this purpose.
Because the liver is the primary organ that cleanses and detoxifies the blood, many detoxification programs include a component of liver support or what is often called liver cleansing. Milk thistle is commonly included in Western detoxification regimens. Although there is preclinical evidence supporting the fact that milk thistle can protect the liver against damage from toxins and stimulate the transcription and activity of phase II detoxification enzymes, no clinical studies have examined the effects of the use of milk thistle for this general detoxification purpose.
Milk thistle is part of a typical naturopathic approach to a cleansing and detoxification protocol. These protocols emphasize up-regulating the body's elimination pathways through bowel movements, urine, and sweat, while ingesting nourishing foods and botanicals. Such a protocol typically includes eating a whole foods diet to increase phytonutrient intake, increase fiber intake, and decrease exposure to food additives; increasing frequency of bowel movements by increasing fiber intake, eating foods that promote bowel movements (eg, beets), and ingesting botanical preparations that promote bowel movements (eg, senna leaf, or Cassia angustifolia); increasing water intake to increase urinary excretion; promoting sweating through light exercise or sauna; and ingesting botanical preparations to support hepatic function and regenerate hepatocytes (eg, milk thistle). 4
Use as a Hepatoprotectant and to Prevent Hepatotoxicity During Chemotherapy
Milk thistle has been studied for its use as a hepatoprotectant and for preventing hepatotoxicity attributable to exogenous exposures. Most of this research has been in exposures to alcohol 7, 8 and drugs, [9] [10] [11] [12] occupational exposures such as toluene and xylene, 13, 14 and ingestion of Amanita phalloides mushrooms. [15] [16] [17] [18] [19] [20] [21] [22] Chemotherapy is a conceptual analog to these hepatic toxins. Many forms of chemotherapy are metabolized by the liver and can increase liver enzymes or cause hepatotoxicity. Hepatotoxicity is a frequent toxicity that can result in chemotherapy dose reductions or withdrawal in adult and pediatric populations. Compromised liver function may also be attributable to hepatocellular carcinoma or tumor metastasis. Studies are beginning to examine the use of milk thistle in treating chemotherapyinduced hepatotoxicity and protecting the liver during chemotherapy.
Milk thistle is used by many patients and clinicians to prevent hepatotoxicity attributable to chemotherapy. Chemotherapy agents that are likely to produce hepatotoxicity include dactinomycin, daunorubicin, docetaxel, gemcitabine, imatinib, 6-mercaptopurine, methotrexate, and oxaliplatin. 23, 24 Cancer patients taking these therapies often self-medicate with milk thistle because of its reputation as a liver protectant. Clinicians also prescribe it to cancer patients for the same purpose. 5, 6 The rationale is to provide support to the liver while it performs multiple functions, including responding to increased metabolic demands caused by tumor growth, assisting in metabolizing products generated when a tumor is killed or reduced by chemotherapy and radiation, and aiding in the processing of drugs prescribed to cancer patients. However, some clinicians recommend against milk thistle's use in liver cancer out of a speculative concern that milk thistle's ability to stimulate hepatocyte regeneration may stimulate the growth of hepatocytes and thus may stimulate the growth of the tumor (D. Edelstein, personal communication, March 2005).
The effect of milk thistle on chemotherapy-induced hepatic toxicity in patients receiving cancer therapy is largely unknown. One case report described the use of silymarin in a 34-year-old woman with promyelocytic leukemia. 25 The investigators administered 800 mg/d silymarin during the patient's methotrexate and 6-mercaptopurine maintenance therapy. During the 4 months of treatment with silymarin, the patient had normal liver enzyme levels, and there was no further interruption of therapy.
Only 1 randomized, double-blind study has reported the effects of milk thistle on hepatotoxicity in patients receiving cancer therapy. Fifty children with acute lymphoblastic leukemia (ALL) and grade 2 or higher hepatic toxicity were randomized to receive a milk thistle supplement (Siliphos, Thorne Research, Dover, Idaho) (5.1 mg/kg/d) or placebo for 28 days. 26 The authors reported significant reductions in mean aspartate aminotransferase (AST; P < .05) and a trend toward a significant reduction in alanine aminotransferase (ALT; P < .07). More children in the milk thistle group developed a greater than 50% reduction in total bilirubin at day 28 compared with placebo (P = .0069). These encouraging findings are currently being followed by a larger cohort of children with ALL through the NCI Children's Oncology Group (K. Kelly, personal communication, 2007).
Other Protective Effects
Milk thistle may confer additional protective effects during cancer treatment, including serving as a kidney protectant and a cardioprotectant and reducing adverse effects of anesthesia.
Milk Thistle as Kidney Protectant
In addition to being a hepatoprotectant, milk thistle can also be considered a kidney protectant, although it is not widely used for this purpose in clinical practice. North American physicians used a strong tincture of milk thistle to treat congestion of the kidneys and hematuria in the late 1800s. 2 Studies in diabetes and in chemotherapy animal models suggest interesting renal protectant mechanisms.
A recent clinical trial in patients with end-stage diabetic nephropathy showed that treatment with silymarin corrected thiol deficiency, increased T cell activation, and reduced tumor necrosis factor-α, thus normalizing immunoregulatory defects. 27 During continuous ambulatory peritoneal dialysis, macrophages are highly compromised, possibly attributable to a thiol-disulfide imbalance. Peritoneal macrophages treated with silymarin or silibinin stabilized cellular thiol status with a resulting improvement of phagocytosis. 28 Some chemotherapy regimens can cause nephrotoxicity. 29 No clinical trials have been reported using milk thistle to prevent chemotherapy-induced nephrotoxicity. However, animal model studies suggest possible protective effects. In a preclinical study, silibinin prevented the renal damage usually caused by cisplatin and ifosfamide in a rat testicular cancer model. 30 Silibinin also prevented renal damage by cisplatin in another study of healthy rats. 31 In rats, silybin prevented cisplatin-induced glomerular and tubular nephrotoxicity as measured by blood urea nitrogen, creatinine and fibronectin, and histologic changes in renal tubules. 30, 31 Silibinin and silycristin exerted a protective effect on monkey kidney cells. 12 In vitro experiments with monkey kidney cells damaged by cisplatin and vincristine showed that treatment with silibin before or after chemically induced injury can lessen or prevent the nephrotoxicity of these drugs. 32 Milk thistle may also protect the kidney from radiation damage. Administered orally before exposure to gamma radiation, silymarin had significant protective effects on urea and creatinine serum levels in an animal model. 33
Milk Thistle as Cardioprotectant
Milk thistle may protect against chemotherapy-induced cardiotoxicity. Silymarin and its constituents protected rat heart microsomes and mitochondria against doxorubicin-induced lipid peroxidation, suggesting that the herb may possibly prevent doxorubicinmediated damage to the heart. 34
Milk Thistle as Anesthesia Protectant
Milk thistle is often recommended to patients before surgery to help them cope with adverse effects of anesthesia. 4 Silymarin extracts (420 mg/d) prevented liver damage attributable to general anesthetics in patients undergoing major surgeries in controlled clinical trials. 35 
Adjunct to Cancer Treatment
Milk thistle may also serve as an adjunct to chemotherapy and radiation therapy to potentiate the treatments.
Radiation Therapy Adjunct
Milk thistle may benefit patients undergoing radiation therapy. In a nonrandomized study, patients with brain metastases received stereotactic radiotherapy alone (n = 262) or stereotactic radiotherapy plus omega 3 fatty acids and silymarin (n = 143). Patients taking omega 3 fatty acids and silymarin had longer survival times and a smaller number of radionecroses. 36 In rats, silymarin administered 1 hour before gamma irradiation moderated radiation-induced changes in the spleen, liver, and bone marrow. 37
Chemotherapy Adjunct
In vitro and animal data suggest that milk thistle may increase the uptake and actions of chemotherapeutic agents. Silymarin increased daunomycin accumulation, potentiated doxorubicin toxicity, and inhibited efflux of these drugs from cancer cells. 38 Silibinin potentiated the antitumor action of cisplatin in vivo and in vitro and reduced recovery time in mice administered with cisplatin. 39 In a T cell, acute lymphoblastic leukemia cell line (CCRF-CEM), silibinin at higher doses (30 µM) was synergistic with vincristine but not L-asparaginase. There were no effects at low doses (10 µM). 40 In germ cell tumors, silibinin did not interfere with the antineoplastic effects of cisplatin or ifosfamide. Silibinin may increase the chemosensitivity of DU 145 prostate cancer cells resistant to chemotherapy. 41 It is unknown whether milk thistle could also increase the adverse effects of chemotherapy (eg, neutropenia).
Direct Anticancer Effects
Milk thistle may also have a role in preventing and treating cancer. Animal and in vitro models are being used to better understand the mechanisms by which silymarin may act in cancer prevention and treatment. The areas of research receiving the most attention are in prostate, skin, and colorectal cancers. The preclinical use of milk thistle as an anticancer agent is thoroughly reviewed elsewhere in this journal issue. 42 Preliminary clinical research is starting to become available on the effects of milk thistle for cancer prevention. A phase I colorectal cancer chemoprevention study showed that it is possible to achieve biologically active doses using silibinin formulated with phosphatidylcholine. 43 Another clinical study found that topical silymarin significantly reduced ultraviolet (UV)-induced erythema in humans, and hence topical silymarin may be a beneficial supplement to sunscreen protection to increase anticarcinogenic protection and prevent other UV-mediated damage. [44] [45] [46] Milk thistle is also under preliminary investigations for its possible role in treating cancer. A phase I study of silibinin in treating hormone refractory prostate cancer showed that it is possible to achieve biologically active blood levels using silibinin powder mixed in apple sauce. 47 Of note, a case report described a 52-year-old man with unresectable biopsy-proven hepato cellular carcinoma. 48 The patient began taking 450 mg of silymarin per day, and spontaneous regression of the tumor was reported in the absence of initiation of anticancer therapy. These findings have not been tested in a clinical trial.
Ameliorating Long-Term Effects of Cancer Treatment
Because patients with cancer are living longer, they are coping with long-term side effects of treatment, developing late effects related to their cancer (especially pediatric populations), and developing comorbidities unrelated to their cancer. Some of these disorders may be ameliorated by milk thistle, especially disorders related to hepatic and cardiovascular function.
Liver Diseases
Milk thistle is primarily used in clinical practice to protect, support, and repair the liver. As discussed above, milk thistle can be used as a hepatoprotectant and to treat hepatotoxicity caused by chemotherapeutic agents. Hepatic toxicity can also result from the prolonged use of total parenteral nutrition and is frequently encountered in patients undergoing stem cell transplantation. However, much of the literature on milk thistle is in individuals with liver disease unrelated to cancer or cancer therapy.
Few clinicians use milk thistle extracts as the sole therapy for patients with these serious liver diseases. The existing, although rather limited, clinical trial data suggest that milk thistle extract is not an effective monotherapy for alcoholic or hepatitis B-or C-related liver diseases. 49, 50 However, milk thistle is very commonly used in combination with other hepatoprotective agents. Two case series showed preliminary support for combining natural therapies in patients with chronic hepatitis C. The first showed that a combination of α-lipoic acid, milk thistle extract, and selenium in conjunction with dietary and lifestyle changes reduced serum transaminase levels and viral load. 51 The second case series examined the effect of a multiagent protocol using colchine, ursodeoxycholic acid, milk thistle extract, an antioxidant combination, cod liver oil, fiber supplement, and a variety of herbal extracts. 52 Seven patients not treated with interferon who followed this protocol for 1 month had a significant reduction in serum ALT levels, whereas 7 had no change or slight increases. No patients developed symptoms of advanced liver disease such as ascites or jaundice.
Cardiovascular
Cancer patients are at risk of cardiovascular disease after receiving chemotherapy, specifically anthracyclinebased chemotherapy. These side effects of therapy can include elevated cholesterol, elevated low-density lipoprotein, elevated triglycerides, and damage to the cardiovascular muscle. For example, children with leukemia receiving L-asparaginase and patients treated with bexarotene for cutaneous T cell lymphoma are at increased risk for elevated triglycerides. 53, 54 Similarly, aromatase inhibitors for the treatment of breast cancer may elevate cholesterol levels. 55 Preliminary research provides some support for using milk thistle for these conditions.
Milk thistle may affect lipid levels. Among 15 cholecystectomy patients, those who received milk thistle extract 420 mg/d for 30 days had a significant decrease in biliary cholesterol concentration versus those treated with placebo, suggesting decreased hepatic cholesterol synthesis. 56 In a 7-month open clinical study in 14 type II hyperlipidemic outpatients, treatment with milk thistle extract 420 mg/d was associated with a decrease in serum total cholesterol and an increase in serum highdensity lipoprotein cholesterol levels. 57 In a 6-month, double-blind, randomized trial of patients with poorly controlled non-insulin-dependent diabetes mellitus and alcoholic liver disease, 135 mg/d silibinin-β-cyclodextrin was shown to significantly reduce serum triglyceride levels compared with placebo. 58 Cholesterol levels were not affected.
In another study, milk thistle seed oil was found to significantly reduce serum total cholesterol and triglyceride levels (84% and 60%, respectively) in rats. 59
Diabetes Mellitus
Cancer survivors, especially survivors of childhood cancers, are at increased risk of developing diabetes. 60, 61 Preliminary studies in noncancer populations suggest an effect of milk thistle in diabetes treatment. Although milk thistle is not widely used in patients with diabetes, clinical studies indicate that milk thistle may be of benefit in diabetes caused by alcoholic liver cirrhosis and heavy alcohol use. 58, 62, 63 Milk thistle may diminish the tissue insulin resistance in these types of diabetes and may also prevent diabetic sequelae such as neuropathy and retinopathy.
In a double-blind trial, silybin-β-cyclodextrin 135 mg/d was compared with placebo in 42 patients with alcoholic liver disease and concomitant noninsulin-dependent diabetes mellitus. 58 Fasting serum glucose and triglyceride levels declined significantly in the silybin group compared with the placebo group, with a trend toward lower hemoglobin A1c (HbA1c) levels in the silybin group.
In a 12-month, unblinded, controlled study of insulin-treated subjects (n = 60), 600 mg/d silymarin significantly decreased fasting glucose levels, mean daily glucose levels, daily glucosuria, and HbA1c levels after 4 months of treatment. 62 Compared with controls, subjects in the silymarin-treated group also showed significant decreases in fasting insulin levels, mean exogenous insulin requirements, and basaland glucagon-stimulated C peptide levels.
A randomized, controlled trial using 600 mg/d silymarin for 6 months in alcoholic diabetics (n = 60) showed statistically significant decreases in mean levels of fasting blood glucose, daily blood glucose, daily glycosuria, glycosylated hemoglobin, daily insulin need, fasting insulinemia, blood malondialdehyde, and basal-and glucagon-stimulated C peptide when subjects in the active arm were compared with controls and with their own baseline values. 63
Commonly Used Forms of Milk Thistle and Doses
Milk thistle is best known for the actions of silymarin, a flavonolignan complex that includes silibinin, silydianin, isosilybin, and silychristin. Unprocessed milk thistle seeds usually contain 4% to 6% silymarin. Many commercial preparations are standardized to contain 70% to 80% silymarin content using its primary flavonolignan silibinin as the reference. Essentially all clinical trials have been based on these standardized products. Clinicians who practice based largely on clinical trial evidence will generally choose to use silymarin standardized products, generally at a dose of 140 mg 3 times per day. 64 Table 1 shows commonly used adult and pediatric dosages of various milk thistle preparations, including rationales for use of the different preparations.
Milk thistle seed decoctions, prepared by boiling the seeds in water, have been used medicinally since the Greco-Roman era. Eclectic physicians (American physicians who relied on natural medicines) in the late 1800s reported good success for a range of conditions using strong tinctures of milk thistle seed, prepared by soaking the seeds in ethanol, that could not have contained more than 5% to 6% silymarin. 65 Many studies suggest that silymarin provides benefits at very low levels, and no research has been done comparing the clinical effectiveness of various doses and types of preparations. A few studies show benefits from low silymarin-containing forms of milk thistle. 66, 67 Clinicians who practice primarily based on traditional uses will tend to favor various crude extracts of milk thistle as opposed to standardized extracts.
When milk thistle is used for liver support or for detoxification in generally healthy patients, clinicians often dispense milk thistle as infusions, decoctions, tinctures, fluid extracts, and nonconcentrated capsules. In specific disease states, to more closely mirror the research protocols, the concentrated and standardized products will typically be used. In cancer, the potential cytotoxicity of silibinin and isosilybin sometimes leads to a preference for the more bioavailable forms of preparations. However, a recent animal study showed that high levels of silibinin actually promoted the growth of mammary tumors, bringing into question the current trend toward increasing the amount and availability of silibinin. 68 However, this dose may be difficult to achieve in humans. 47 Further studies are definitely needed to compare the effectiveness of less silymarin-enriched forms of milk thistle with the standardized extracts.
Adverse Events
Human studies of silymarin have shown minimal adverse effects in multiple large, blinded, placebocontrolled, randomized studies. Silymarin is well tolerated, with only rare reports of a mild laxative effect. Mild allergic reactions have been seen at high doses (>1500 mg/d), although the details of these allergic reactions were not reported. 69 A case report from Australia described a reaction to a milk thistle extract that included intermittent episodes of sweating, abdominal cramping, nausea, vomiting, diarrhea, and weakness. 70 All symptoms resolved when the silymarin was discontinued; however, later reports on this case study suggested that the capsules may have been contaminated. The type of contamination was unknown.
According to the German Commission E, there are no reported side effects with milk thistle within the recommended doses. 1 Rare cases of milk thistle having a laxative effect have been reported. Human studies have reported stomach upset, heartburn, and transient headaches, but none of these symptoms were attributed to supplementation with milk thistle, and supplementation was not discontinued. 71 One human dosing study reported nausea, heartburn, and dyspepsia in subjects treated with 160 mg/d; dyspepsia in patients treated with 240 mg/d; and postprandial nausea and meteorism in patients treated with 360 mg/d. None of these side effects were dose related.
Silymarin has been well tolerated in high doses. Silymarin has been used in pregnant women with intrahepatic cholestasis at doses of 560 mg/d for 16 days with no observed toxicity to the patient or the fetus. 72 The published data on silymarin use in children focus on intravenous doses of 20 to 50 mg/kg body weight for mushroom poisoning. 20 A phase I study in men with prostate cancer found that administration of silibinin-phytosome (Siliphos) was well tolerated; however, gastrointestinal toxicities were observed at elevated doses. 47 Grade 1 or 2 hyperbilirubinemia was observed at a dose of 15 g/d or higher. Grade 1, 2, and 3 elevations in AST and ALT were also observed at 13 g/d and higher. The authors hypothesized that these unexpected toxicities may be attributable to milk thistle's ability to inhibit uridinediphosphoglucuronate-glucuronosyltransferase, which plays a pivotal role in the conjugation of bilirubin and the metabolism of irinotecan. 73 Milk thistle's effect on the metabolism of irinotecan was investigated in patients with colon cancer. 43 The authors supplemented patients with 200 mg of milk thistle and found no adverse effect on the metabolism of irinotecan. The available data appear to indicate that milk thistle has few side effects associated with doses less than 5 g/d. One trial supports an increased incidence of adverse effects with doses greater than 10 g/d. Future trials are needed to provide dosing guidelines for the use of milk thistle as a supportive care agent compared with its use as an antitumor drug.
Conclusion
Milk thistle is an herb that is generally safe and well tolerated and has clinical applications in a variety of settings. The most common settings are hepatic and biliary, but it can also be considered for use in renal, cardiovascular, and endocrinological settings. Research in applications of milk thistle in oncological settings is expanding. Additional clinical research is needed in all of these areas to further clarify the clinical effects of milk thistle.
